Ivermectin/Pyrantel Pamoate/Praziquantel

Verify with FDA CVM →

787 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
787
Total Reports
6
Deaths Reported
80.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel Pamoate/Praziquantel

Administration Routes

OralUnknown

Species Affected

Dog 765
Unknown 22

Most Affected Breeds

Retriever - Labrador 80
Crossbred Canine/dog 49
Shih Tzu 37
Dog (unknown) 32
Maltese 32
Chihuahua 31
Terrier - Yorkshire 29
Beagle 25
Unknown 22
Shepherd Dog - German 21

Most Reported Reactions

Vomiting 376
Lack of efficacy - NOS 143
INEFFECTIVE, HEARTWORM LARVAE 96
Diarrhoea 91
Lack of efficacy (endoparasite) - hookworm 85
INEFFECTIVE, ASCARIDS NOS 73
Lethargy (see also Central nervous system depression in 'Neurological') 72
Overdose 21
Panting 16
Uncoded sign 15
Underfilling, Package 15
Lack of efficacy (endoparasite) - tapeworm 14

Outcome Breakdown

Recovered/Normal
420 (54.9%)
Outcome Unknown
291 (38.0%)
Ongoing
38 (5.0%)
Recovered with Sequela
10 (1.3%)
Died
3 (0.4%)
Euthanized
3 (0.4%)

Data Summary

Metric Value
Total adverse event reports 787
Reports involving death 6
Case-fatality rate (reported events) 80.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Pamoate/Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 787 adverse event reports referencing Ivermectin/Pyrantel Pamoate/Praziquantel, including 6 reports in which the animal died — a 80.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Pamoate/Praziquantel. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel Pamoate/Praziquantel reports are Dog (765 reports), Unknown (22 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (80), Crossbred Canine/dog (49), Shih Tzu (37) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel Pamoate/Praziquantel are Vomiting (376), Lack of efficacy - NOS (143), INEFFECTIVE, HEARTWORM LARVAE (96), Diarrhoea (91). Of the 765 reports with a coded outcome, Recovered/Normal is the leading category at 54.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Pamoate/Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial